2LGB | Modified A22Gly-B31Arg Human Insulin | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Bocian, W., Kozerski, L. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Recombinant A22(G)-B31 (R)-human insulin. A22 addition introduces conformational mobility in B chain C-terminus., Borowicz P, Bednarek E, Bocian W, Sitkowski J, Jaworska B, Mikolajczyk J, Glabski T, Stadnik D, Surmacz W, Bogiel M, Kozerski L, J Biomol NMR. 2012 Apr;52(4):365-70. Epub 2012 Feb 14. PMID:22350952 |
Data retrieval |
View 2LGB in 3D |
Visual 3D analysis of 2LGB |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2LGB |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |